News

Fewer U.S. Teens Using Illegal Drugs and Alcohol

Plus, teen tobacco use fell to new low in 2013, government statistics show

Routine ECGs for Young Athletes Not Advised

U.S. heart experts recommend doctors use a 14-point checklist rather than an electrocardiogram (ECG) when evaluating young people for underlying heart disease that could result in sudden cardiac arrest.

Exercise May Delay Age-Related Hypertension in Men

Aerobic exercise leading to strong cardiorespiratory fitness can delay a man's onset of age-related high blood pressure.

Radiotherapy Improves Dysphagia in Esophageal Cancer

For patients with advanced esophageal cancer, dysphagia is improved with radiotherapy alone.

QoL Up with Testosterone Recovery in Prostate Cancer

For patients with high-risk prostate cancer, testosterone recovery is shorter for patients receiving 18 months vs. 36 months of androgen deprivation therapy (ADT), and is associated with improved quality of life.

CDC Advises Clinicians on Rare Respiratory Illness Outbreak

The Centers for Disease Control and Prevention (CDC) has issued an update regarding the outbreak of severe respiratory illness caused by the rare Enterovirus D68 (EV-D68) and recommendations for clinicians.

First-in-Class Movantik Approved for Opioid-Induced Constipation

The Food and Drug Administration has approved Movantik (naloxegol; AstraZeneca) for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

Chocolate-Flavored OTC Cough/Cold Products Launched

infirst Healthcare announced the launch of the Dr. Cocoa for Children product line, which consists of 3 over-the-counter (OTC) cough and cold medicines with 10% real cocoa for real chocolate taste to improve compliance.

First Glucose Meter with Insulin Calculator Available

Roche announced the launch of Accu-Chek Aviva Expert system, the first blood glucose meter with a built-in insulin calculator.

Uceris Rectal Foam for Distal Ulcerative Colitis Granted Tentative Approval

Salix announced that the Food and Drug Administration (FDA) has granted tentative approval for Uceris (budesonide) rectal foam for the induction of remission in patients with active mild-to-moderate distal ulcerative colitis (UC) extending up to 40cm from the anal verge.